🇺🇸 FDA
Patent

US 8263662

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

granted A61KA61K31/145A61K45/06

Quick answer

US patent 8263662 (Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products) held by The Regents of the University of California expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/145, A61K45/06, A61K9/4891, A61P